Skip to Content

A31 (Oxybutynin Chloride Extended-Release 5 mg)

Pill with imprint A31 is Purple, Round and has been identified as Oxybutynin Chloride Extended-Release 5 mg. It is supplied by Amneal Pharmaceuticals of New York, LLC.

Oxybutynin is used in the treatment of urinary frequency; urinary incontinence; dysuria and belongs to the drug class urinary antispasmodics. There is no proven risk in humans during pregnancy. Oxybutynin 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for A31

Oxybutynin chloride extended-release 5 mg A31
Oxybutynin chloride extended-release 5 mg A31
Oxybutynin chloride extended-release 5 mg A31

Oxybutynin Chloride Extended-Release

Imprint
A31
Strength
5 mg
Color
Purple
Shape
Round
Availability
Rx and/or OTC
Drug Class
Urinary antispasmodics
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Amneal Pharmaceuticals of New York, LLC

Labelers / Repackagers

NDC CodeLabeler / Repackager
65162-0371 Amneal Pharmaceuticals LLC
42291-0540 AvKare, Inc.
10135-0609 Marlex Pharmaceuticals Inc.
00904-6570 Major Pharmaceuticals

Get help with Imprint Code FAQs.

Related Images for "A31"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.